Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 13;61(17):7952-7976.
doi: 10.1021/acs.jmedchem.8b01011. Epub 2018 Aug 20.

2,4,6-Substituted Quinazolines With Extraordinary Inhibitory Potency Toward ABCG2

Affiliations

2,4,6-Substituted Quinazolines With Extraordinary Inhibitory Potency Toward ABCG2

Michael K Krapf et al. J Med Chem. .

Abstract

Several members of the ABC transporter superfamily play a decisive role in the development of multidrug resistance (MDR) in cancer. One of these MDR associated efflux transporters is ABCG2. One way to overcome this MDR is the coadministration of potent inhibitors of ABCG2. In this study, we identified novel inhibitors containing a 2,4,6-substituted quinazoline scaffold. Introduction of a 6-nitro function led to extraordinarily potent compounds that were highly selective for ABCG2 and also able to reverse the MDR toward the chemotherapeutic drugs SN-38 and mitoxantrone. The binding of substrate Hoechst 33342 and the two potent inhibitors 31 and 41 which differ in their mechanism of inhibition was rationalized using the recently published cryo-EM structures of ABCG2. For a better understanding of the interaction between the inhibitors and ABCG2, additional investigations regarding the ATPase activity, the interaction with Hoechst 33342, and with the conformational sensitive 5D3 antibody were carried out.

Similar articles

See all similar articles

MeSH terms

Substances

LinkOut - more resources

Feedback